🔓
Sign in as a Member to unlock the full view of BMY. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$29.99/mo already a Member? Sign in →
BMY

Bristol-Myers Squibb Company

Sector: pharmaDrug Manufacturers - GeneralNYSEMarket Cap: $128.81B

Bristol-Myers Squibb Company (BMY) is a global biopharmaceutical company with a dominant political signal being $30.5M in 2024 doctor payments via E.R. Squibb & Sons, L.L.C. and executive branch holdings by Donald J. Trump valued up to $100,000.

Next filing → your inbox
Govt Dependence
35/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL

BusinessWhat BMY does

Bristol-Myers Squibb Company discovers, develops, and commercializes pharmaceuticals for oncology, immunology, cardiovascular, and neuroscience diseases. Revenue is generated through global sales of prescription drugs, with significant income from key products like Opdivo and Eliquis. The company also engages in partnerships and acquisitions to expand its pipeline.

12 months past · 3 months futureBMY activity timeline

$70$57$44 DecJan '26FebMarAprMayJunJulAugSepOctNovDecJan '27Feb ↓ PAST — recorded activity ↑ FUTURE — scheduled markups · pending votes TODAY · Nov 17 $68.09 hi $45.79 lo $62.93 CONGRESS 30 INSIDERS 0 13F FUNDS 30 BILLS 28 Ro Khanna (D) · Sale · 2026-10-07Ro Khanna (D) · Purchase · 2026-10-13Mike Kelly (R) · Sale · 2026-05-07Ro Khanna (D) · Purchase · 2026-01-23Ro Khanna (D) · Sale · 2026-01-29Julie Johnson (D) · Sale · 2025-12-18Gilbert Ray Cisneros (D) · Purchase · 2025-12-19 AQR Capital Management · OPENED $1797M · 2026-03-31AQR Capital Management · - $1576M · 2026-06-30Two Sigma Investments · + $703M · 2026-03-31Two Sigma Investments · - $582M · 2026-06-30Citadel Advisors · + $578M · 2026-03-31Millennium Management · + $446M · 2026-03-31Citadel Advisors · - $443M · 2026-06-30Two Sigma Investments · - $251M · 2025-12-31Citadel Advisors · holds $216M · 2025-12-31Renaissance Technologies · - $127M · 2025-12-31 MARKUP · Senate Veterans' Affairs · 2026-11-18MARKUP · Senate Health, Education, Labor, and Pensions · 2026-11-18MARKUP · Senate Veterans' Affairs · 2026-11-18
Congress
buy sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened + added − trimmed closed holds
Bills
past action (this ticker) upcoming markup (sector) ★ carveout (this ticker)
250 trading days · 7 congressional trades shown · 0 insider buys · 10 13F filings · 0 past bill actions · 3 upcoming markups

Executive Branch ConflictsBMY held by Trump-administration officials

Lifetime Government AwardsBMY federal contracts by year

$21M
total awarded · 2011–2026
108
contracts on file
2025
peak year ($8M)
$8M $4M 2011: $0 across 3 contracts $0 2011 3 contracts 2012: $83K across 3 contracts $83K 2012 3 contracts 2016: $1 across 2 contracts $1 2016 2 contracts 2022: $313K across 1 contract $313K 2022 2023: $1M across 4 contracts $1M 2023 4 contracts 2024: $4M across 18 contracts $4M 2024 18 contracts 2025: $8M across 25 contracts (peak year) $8M 2025 25 contracts 2026: $7M across 52 contracts $7M 2026 52 contracts
Top contracts by award amount
$1.0M Department of Veterans Affairs 2026-10-01 CAMZYOS AND POMALYST
$848K Department of Veterans Affairs 2025-12-31 REVLIMID, POMALYST, CAMZYOS SPECIALTY PHARMACEUTICALS
$670K Department of Veterans Affairs 2025-05-15 EMERGENCY BREYANZI INFUSION
$379K Department of Veterans Affairs 2026-03-13 ABECMA FOR CAR-T
$364K Department of Veterans Affairs 2026-05-29 BREYANZI CAR T-TRANSPLANT
16 years · 108 contracts

Smart Money · 13F HoldingsHedge funds holding BMY

$2.86B
Total BMY held by tracked 13F funds
7
Funds with BMY positions
+1
Funds opened this quarter
AQR Capital Management $1.58B -8% 1 overlap 2026-06-30
Two Sigma Investments $582M -13% 1 overlap 2026-06-30
Citadel Advisors $443M -19% 1 overlap 2026-06-30
D.E. Shaw & Co. $97M +59% 1 overlap 2026-06-30
Millennium Management $86M -80% 1 overlap 2026-06-30
Point72 Asset Management $78M +24% 1 overlap 2026-06-30
Renaissance Technologies $1M opened 2 overlap 2026-09-30

Politicians Trading BMYMembers of Congress with recent BMY positions

9 politicians traded BMY across 40 disclosed transactions totaling $418K (last 730 days). Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just BMY). 0-30 LOW · 30-60 MID · 60+ HIGH.

Congressional TradesWho in Congress is trading BMY

2026-10-07 Ro Khanna D-California · house Sale $1,001 - $15,000
2026-10-13 Ro Khanna D-California · house Purchase $1,001 - $15,000
2025-04-15 Tommy Tuberville R-Alabama · senate Sale $1,001 - $15,000 477d late
2026-05-07 Mike Kelly R-Pennsylvania · house Sale $15,001 - $50,000
2026-01-23 Ro Khanna D-California · house Purchase $1,001 - $15,000
2026-01-29 Ro Khanna D-California · house Sale $15,001 - $50,000
2025-12-18 Julie Johnson D-Texas · house Sale $1,001 - $15,000
2024-10-23 Julia Letlow R-Louisiana · house Purchase $1,001 - $15,000 447d late
2025-04-28 Julia Letlow R-Louisiana · house Sale $1,001 - $15,000 260d late
2025-12-19 Gilbert Ray Cisneros D-California · house Purchase $1,001 - $15,000
2025-11-12 Gilbert Ray Cisneros D-California · house Purchase $1,001 - $15,000
2025-11-13 Julie Johnson D-Texas · house Sale $1,001 - $15,000
30+ trades on file · most recent 2026-11-05

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

Stock awards & option exercises

8
option exercises · $5.2M
For BMY, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.

Bills Affecting BMYLive legislation impacting this stock

Political ProfileWhere BMY sits in Washington

[object Object]

STRUCTURAL: Executive branch holdings by Trump ($50,001-$100,000) and Democrat donation alignment ($5,000 to Joyce Beatty). EVIDENTIARY: No recent corporate insider buys in 180-day window (get_corporate_insider_signal.score 0, tier F), but three Form 4 buys in 2025 totaling ~$412K. Net: Mixed signals with high regulatory density but low trading activity.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • Pharmaceutical pricing legislation
    Congress
    "Recent bill_impacts array shows 8 bills with impact_ratios 0.0001-0.0002, each estimated to impact revenue by $15M-$22.5M."
  • Increased transparency in doctor payments
    CMS
    "get_political_influence.doctor_payments shows $30.5M in 2024 payments via E.R. Squibb & Sons, L.L.C., potentially subject to disclosure regulations."

Regulatory opportunities

  • Federal contracts for pharmaceuticals
    Department of Veterans Affairs
    "get_government_precedent.federal_contracts_summary[0] shows $17.5M total obligation across 80 contracts, including with VA."
  • Executive branch stock holdings may indicate favorable policy views
    White House
    "get_executive_branch_exposure.by_ticker[0].holdings shows Donald J. Trump holds BMY stock valued $50,001-$100,000."

Capitol Hill AlliesChampions & critics

Congressional champions

Congressional critics

  • No specific congressional critics identified.
Member intelligence layer

Live signals + predictions for BMY — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $29.99/mo Locked rate forever · cancel anytime

Frequently AskedAbout BMY & political exposure

Does Bristol-Myers Squibb Company (BMY) hold federal contracts?
Yes. Bristol-Myers Squibb Company has 108 federal contract awards totaling $20,736,047, primarily from agencies including Department of Justice, Department of Veterans Affairs. See full contract list and amounts on this page.
Which Trump cabinet officials own BMY stock?
2 Trump cabinet members or senior White House staff have disclosed holdings in BMY on their OGE 278 financial disclosures, including Donald J. Trump, Lori Chavez-DeRemer. See the Cabinet Conflicts panel for details.
Has Congress traded BMY stock?
416 congressional trades by 46 unique members of Congress, most recently on 2026-10-13. See the Congressional Trading panel for politician-by-politician breakdown.
What is BMY political risk profile?
Government dependence: 35/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 100%.
How does GovGreed track BMY political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. BMY data is updated daily from these official federal sources.